66 related articles for article (PubMed ID: 17604264)
61. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
62. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.
Smit P; van Schaik RH; van der Werf M; van den Beld AW; Koper JW; Lindemans J; Pols HA; Brinkmann AO; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 2005 Sep; 90(9):5313-6. PubMed ID: 15985487
[TBL] [Abstract][Full Text] [Related]
63. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
64. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
Miklós S
Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
[TBL] [Abstract][Full Text] [Related]
65. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
[TBL] [Abstract][Full Text] [Related]
66. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]